Wound Care News: Breaking Wound Care News, Comments and Articles. - Page: 2

Discovery of a novel medicine for the treatment of chronic wounds

(Umea University) Every 20 seconds, a limb is lost as a consequence of a diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. In his doctoral thesis, Yue Shen from the Industrial Doctoral...

P values or confidence intervals?

The effectiveness of topical chloramphenicol in preventing wound infection after minor dermatological surgery was evaluated. Researchers performed a randomised placebo controlled double blind...

Robotic transplantation may reduce health disparities for obese patients with chronic kidney failure

Obese patients who received robotic kidney transplants had fewer wound complications than patients who received traditional "open" transplant surgery, according to surgeons at the University of Illinois Hospital & Health Sciences System.

Chandler, AZ - Wound Healing Center Celebrates Ten Years

In May 2003, Chandler Regional Medical Center's Wound Healing and Hyperbaric Oxygen Center opened its doors to treat various wounds that require specialized care. Since then, the Wound Healing and Hyperbaric Oxygen Center has become an integral part of Chandler Regional's services. The center's staff is able to treat a variety of non-healing wounds and injuries including:

Novadaq to Hold Annual Meeting and Ring NASDAQ Stock Market Bell

TORONTO, ONTARIO -- (Marketwired) -- 05/17/13 -- Novadaq® Technologies Inc. ("Novadaq" or the "Company") (TSX: NDQ)(NASDAQ: NVDQ), a developer of clinically-relevant fluorescence imaging solutions for use in surgical and outpatient wound care procedures, announced today that it will hold its Annual Shareholder Meeting on May 22, 2013 in Toronto. Novadaq also announced that President and CEO Dr....

Robotic Kidney Transplants May Be Best Option For Obese Patients

Obese patients who received robotic kidney transplants had fewer wound complications than patients who received traditional "open" transplant surgery, according to surgeons at the University of Illinois Hospital & Health Sciences System. The findings...

Cytomedix to Present at the World Stem Cells & Regenerative Medicine Congress 2013

GAITHERSBURG, MD -- (Marketwired) -- 05/17/13 -- Cytomedix, Inc. (OTCQX: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announced today that Edward Field, the Company's Chief Operating Officer, has been invited to make a presentation on Partnering & Collaboration at the World Stem Cells & Regenerative Medicine C...

Local Arginase 1 Activity Is Required for Cutaneous Wound Healing

Derma Sciences' CEO Discusses Q1 2013 Results - Earnings Call Transcript

Derma Sciences, Inc. (DSCI) Q1 2013 Earnings Conference Call May 16, 2013 11:00 a.m. ET Executives Kim Golodetz - IR, Lippert/Heilshorn & Associates Edward Quilty - President, Chief Executive Officer John Yetter - Chief Financial Officer, Executive Vice President, Finance Barry Wolfenson - Group President of Advanced Wound Care and Pharmaceutical Development Analysts David Amsellem - P...

Target to prevent hardening of arteries identified

The gene Dkk1 encodes a protein that plays a key role in increasing the population of connective-tissue cells during wound repair, but prolonged Dkk1 signaling in cells lining blood vessels can lead to fibrosis and a stiffening of artery walls.

Oxygen Biotherapeutics Receives Favorable NASDAQ Listing Decision

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the “Panel”) has granted the Company’s request for continued listing on The NASDAQ Capital Market pursuant to an extension through June 3, 2013 to evidence compliance with the minimum $1.00 bid price requirement and through July 31, 2013 to evid...

ULURU Inc. Reports First Quarter 2013 Financial Results

ADDISON, Texas, May 16, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the first quarter ended March 31, 2013 and provided a review of its operating activities. Based on the first quarter activities, the Company is confirming the previously communicated outlook for 2013: Launching Altrazeal® onto 15 international markets; Expanding the network...

New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System

Observational Study Showed Significantly Improved Patient Outcomes When the ABThera™ Negative Pressure Therapy System was Used in Open Abdomen Surgery Kinetic Concepts, Inc. announced today that ABThera™ Open Abdomen Negative Pressure Therapy System (ABThera™ OA NPT) was associated with significantly improved patient outcomes compared to...

Derma Sciences Reports First Quarter 2013 Financial Results

Net Sales up 23%; Advanced Wound Care Sales up 67% Including 33% Organic Growth Conference call begins at 11:00 a.m. Eastern time today Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three months ended March 31, 2013. Highli...

Access Pharmaceuticals Reports First Quarter Results

DALLAS and NEW YORK, May 16, 2013 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, released its first quarter ended March 31, 2013 financial results.  The company indicated it will host a conference call at a later date to review financial results and ongoing commercial MuGard progress made within the quarter.  MuGard, Access' lead p...

University General Health System Provides Market Guidance Regarding First Quarter Results

HOUSTON, TX -- (Marketwired) -- 05/16/13 -- University General Health System, Inc. (OTCQB: UGHS), a diversified, integrated multi-specialty health care delivery system, today announced certain preliminary information regarding the quarter ended March 31, 2013. The Company expects to report that first quarter 2013 occupancy at its flagship hospital in Houston exceeded prior-year levels by over 21...

Sanford-Burnham researchers identify target to prevent hardening of arteries

(Sanford-Burnham Medical Research Institute) The gene Dkk1 encodes a protein that plays a key role in increasing the population of connective-tissue cells during wound repair, but prolonged Dkk1 signaling in cells lining blood vessels can lead to fib...

CCS Medical Moves Forward as Medicare Winner

FARMERS BRANCH, Texas, May 15, 2013 /PRNewswire/ -- Effective July 1, CCS Medical, a leading provider of home delivery medical equipment and supplies, will be one of only 18 Medicare mail order suppliers providing diabetic testing supplies nationwide. (Logo: http://photos.prnewswire.com/prnh/20130306/FL72774LOGO) The company, which was named a winner last month in the national Competitive Bid...

RBC Life Sciences Reports First Quarter 2013 Results

IRVING, Texas, May 15, 2013 /PRNewswire/ -- RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $5.7 million for the first quarter ended March 31, 2013, a 6% decrease over the first quarter ended March 31, 2012.  For the first quarter of 2013, the Company reported a...

Dell Helps Trinitas Regional Medical Center Manage Growing Archive of Clinical Images

Trinitas selects Dell to provide scalable, long-term storage with disaster recovery protection Cloud-based, vendor-neutral archive helps improve efficiency, reduce cost and sets the stage for health information exchange Trinitas Regional Medical Center has selected Dell’s Unified Clinical Archive (UCA) solution to m...

New evidence establishes EPA as highly predictive of skin graft failure and supports the utility of Systagenix WOUNDCHEK™ Protease Status point of care test in this application

New evidence presented on Wednesday 15th May 2013 at the European Wound Management Association (EWMA)’s conference in Copenhagen, revealed that elevated protease activity (

ACell MatriStem® Technology Ranks Highest in Constructive Remodeling

COLUMBIA, Md., May 15, 2013 /PRNewswire/ -- ACell, Inc., a leading developer of next-generation regenerative medicine products, announced today that its MatriStem medical devices demonstrate the highest constructive remodeling response in a recent study comparing 14 extracellular matrices (ECM) designed to aid in surgical procedures. The study, "Macrophage phenotype as a predictor of constructive...

Start-Ups, Strategics Help Mend Wound Repair

Large numbers of patients with chronic wounds haven’t responded to existing treatments, and their open wounds can have dire consequences. The suffering of patients, the failures of past remedy attempts, and new financial pressures on hospitals have...

Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments

SAN DIEGO, May 15, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the first quarter ended March 31, 2013, and reported on highlights and other recent developments including: Awarded ISO 13485 Certification for Excellagen, State of California manufacturing license and state clearances to market and sell Excellagen in the U.S., and adva...

Preliminary Study Results Find 47 Percent Fewer Complications, Higher Patient Satisfaction with AQUACEL® Ag SURGICAL Cover Dressing

SKILLMAN, N.J., May 15, 2013 /PRNewswire/ -- Preliminary findings from a new prospective study of complications after knee replacement surgery show a 47 percent decrease in wound complications, such as skin blistering and prolonged healing, when AQUACEL® Ag SURGICAL cover dressing was used, compared with standard surgical dressing. Patients in the study also reported significantly high...